Oxbryta 500 mg Filmtabletten
Recall
|
Medicines
|
30/09/2024
The marketing authorisation holder informed its customers on September 30, 2024, that the medicinal product is being recalled as a precautionary measure due to possible serious side effects that occurred during clinical trials.
| Name of the medicinal product | Oxbryta 500 mg Filmtabletten |
|---|---|
| Marketing authorisation number(s) | EU/1/21/1622/001 |
| CIP code | 5528668 |
| Marketing authorisation holder | Pfizer Europe Ma EEIG |
| Batch number(s) | 2026285 |
| Expiry date | 04/30/2026 |
| Classification of the recall | 1 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4930 |
Further inquiry note
Page last modified:
30/09/2024